Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman(Directorate General of Health Services), Ernesto Yagüe(Imperial College London)
Cited by 90
Related Papers
The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
|Cell Death and Differentiation|2013|90
FOXA1 is a determinant of drug resistance in breast cancer cells
|Breast Cancer Research and Treatment|2021|30
Role of the highly structured 5′-end region of <i>MDR1</i> mRNA in P-glycoprotein expression
|Biochemical Journal|2007|27